78/100B107.460
USD
1.63
(1.54%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Edwards Lifesciences total debt 1999–2026What is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Edwards Lifesciences's total debt was 704.50M USD on 30 September 2026, up 0.6% on a year before. At the end of fiscal year 2025 it was 705.40M USD.
Last updated 10 Nov 2026 · Next report 9 Feb 2027
Total debt
Growth
| Fiscal year | Period ending | Total debt | Growth | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 704.50M | +0.60% | 4.64B | 3.94B | 0.06 |
| FY2025 | 31 Dec 2025 | 705.40M | +0.77% | 4.23B | 3.52B | 0.07 |
| FY2024 | 31 Dec 2024 | 700.00M | +2.17% | 3.98B | 3.28B | 0.07 |
| FY2023 | 31 Dec 2023 | 685.10M | -0.90% | 1.63B | 947.70M | 0.10 |
| FY2022 | 31 Dec 2022 | 691.30M | +0.14% | 1.22B | 524.00M | 0.12 |
| FY2021 | 31 Dec 2021 | 690.30M | -0.66% | 1.47B | 776.50M | 0.12 |
| FY2020 | 31 Dec 2020 | 694.90M | +2.37% | 1.40B | 707.70M | 0.15 |
| FY2019 | 31 Dec 2019 | 678.80M | +14.31% | 1.52B | 838.10M | 0.16 |
| FY2018 | 31 Dec 2018 | 593.80M | -42.71% | 956.50M | 362.70M | 0.19 |
| FY2017 | 31 Dec 2017 | 1.04B | +26.04% | 1.34B | 301.10M | 0.35 |
| FY2016 | 31 Dec 2016 | 822.30M | +37.76% | 1.27B | 448.80M | 0.31 |
| FY2015 | 31 Dec 2015 | 596.90M | -0.20% | 1.22B | 627.80M | 0.24 |
| FY2014 | 31 Dec 2014 | 598.10M | +0.84% | 1.44B | 840.70M | 0.27 |
| FY2013 | 31 Dec 2013 | 593.10M | +213.31% | 936.90M | 343.80M | 0.38 |
| FY2012 | 31 Dec 2012 | 189.30M | +25.86% | 521.40M | 332.10M | 0.13 |
| FY2011 | 31 Dec 2011 | 150.40M | +259.81% | 450.50M | 300.10M | 0.11 |
| FY2010 | 31 Dec 2010 | 41.80M | -53.71% | 396.10M | 354.30M | 0.03 |
| FY2009 | 31 Dec 2009 | 90.30M | -48.55% | 334.10M | 243.80M | 0.08 |
| FY2008 | 31 Dec 2008 | 175.50M | -17.10% | 226.80M | 51.30M | 0.20 |
| FY2007 | 31 Dec 2007 | 211.70M | -10.26% | 191.20M | -20.50M | 0.25 |
| FY2006 | 31 Dec 2006 | 235.90M | -25.37% | 182.80M | -53.10M | 0.31 |
| FY2005 | 31 Dec 2005 | 316.10M | +18.35% | 178.60M | -137.50M | 0.46 |
| FY2004 | 31 Dec 2004 | 267.10M | +4.42% | 48.90M | -218.20M | 0.43 |
| FY2003 | 31 Dec 2003 | 255.80M | +4.20% | 61.10M | -194.70M | 0.40 |
| FY2002 | 31 Dec 2002 | 245.50M | -21.04% | 34.20M | -211.30M | 0.46 |
| FY2001 | 31 Dec 2001 | 310.90M | -27.36% | 48.00M | -262.90M | 0.68 |
| FY2000 | 31 Dec 2000 | 428.00M | — | 28.00M | -400.00M | 0.97 |
| FY1999 | 31 Dec 1999 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| Quarter | Period ending | Total debt | Growth on a year before | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 704.50M | +0.60% | 4.64B | 3.94B | 0.06 |
| Q2 FY2026 | 30 Jun 2026 | 704.40M | +0.26% | 4.25B | 3.55B | 0.07 |
| Q1 FY2026 | 31 Mar 2026 | 702.90M | +0.50% | 3.67B | 2.97B | 0.07 |
| Q4 FY2025 | 31 Dec 2025 | 705.40M | +0.77% | 4.23B | 3.52B | 0.07 |
| Q3 FY2025 | 30 Sept 2025 | 700.30M | -0.91% | 3.84B | 3.14B | 0.07 |
| Q2 FY2025 | 30 Jun 2025 | 702.60M | +1.39% | 4.06B | 3.36B | 0.07 |
| Q1 FY2025 | 31 Mar 2025 | 699.40M | +0.03% | 3.90B | 3.20B | 0.07 |
| Q4 FY2024 | 31 Dec 2024 | 700.00M | +2.17% | 3.98B | 3.28B | 0.07 |
| Q3 FY2024 | 30 Sept 2024 | 706.70M | +2.26% | 4.45B | 3.74B | 0.07 |
| Q2 FY2024 | 30 Jun 2024 | 693.00M | +1.24% | 1.99B | 1.30B | 0.09 |
| Q1 FY2024 | 31 Mar 2024 | 699.20M | +1.66% | 1.70B | 998.40M | 0.10 |
| Q4 FY2023 | 31 Dec 2023 | 685.10M | -0.90% | 1.63B | 947.70M | 0.10 |
| Q3 FY2023 | 30 Sept 2023 | 691.10M | +0.63% | 1.86B | 1.17B | 0.10 |
| Q2 FY2023 | 30 Jun 2023 | 684.50M | +0.25% | 1.51B | 824.80M | 0.11 |
| Q1 FY2023 | 31 Mar 2023 | 687.80M | -0.06% | 1.25B | 566.40M | 0.12 |
| Q4 FY2022 | 31 Dec 2022 | 691.30M | +0.14% | 1.22B | 524.00M | 0.12 |
| Q3 FY2022 | 30 Sept 2022 | 686.80M | +0.39% | 1.74B | 1.05B | 0.11 |
| Q2 FY2022 | 30 Jun 2022 | 682.80M | -0.20% | 1.52B | 833.00M | 0.11 |
| Q1 FY2022 | 31 Mar 2022 | 688.20M | -0.09% | 1.50B | 807.70M | 0.12 |
| Q4 FY2021 | 31 Dec 2021 | 690.30M | -0.66% | 1.47B | 776.50M | 0.12 |
| Q3 FY2021 | 30 Sept 2021 | 684.10M | -0.87% | 1.79B | 1.11B | 0.12 |
| Q2 FY2021 | 30 Jun 2021 | 684.20M | -0.04% | 1.56B | 877.00M | 0.13 |
| Q1 FY2021 | 31 Mar 2021 | 688.80M | +2.01% | 1.33B | 641.80M | 0.15 |
| Q4 FY2020 | 31 Dec 2020 | 694.90M | +2.37% | 1.40B | 707.70M | 0.15 |
| Q3 FY2020 | 30 Sept 2020 | 690.10M | +2.89% | 1.30B | 605.20M | 0.16 |
| Q2 FY2020 | 30 Jun 2020 | 684.50M | +2.42% | 1.16B | 479.30M | 0.18 |
| Q1 FY2020 | 31 Mar 2020 | 675.20M | +1.35% | 1.03B | 355.90M | 0.17 |
| Q4 FY2019 | 31 Dec 2019 | 678.80M | +14.31% | 1.52B | 838.10M | 0.16 |
| Q3 FY2019 | 30 Sept 2019 | 670.70M | -43.80% | 1.36B | 686.20M | 0.18 |
| Q2 FY2019 | 30 Jun 2019 | 668.30M | -43.99% | 934.30M | 266.00M | 0.19 |
| Q1 FY2019 | 31 Mar 2019 | 666.20M | -36.83% | 963.00M | 296.80M | 0.19 |
| Q4 FY2018 | 31 Dec 2018 | 593.80M | -42.71% | 956.50M | 362.70M | 0.19 |
| Q3 FY2018 | 30 Sept 2018 | 1.19B | +15.43% | 1.60B | 402.20M | 0.36 |
| Q2 FY2018 | 30 Jun 2018 | 1.19B | +17.34% | 1.40B | 207.70M | 0.38 |
| Q1 FY2018 | 31 Mar 2018 | 1.05B | +24.38% | 1.50B | 444.70M | 0.32 |
| Q4 FY2017 | 31 Dec 2017 | 1.04B | +26.04% | 1.34B | 301.10M | 0.35 |
| Q3 FY2017 | 30 Sept 2017 | 1.03B | +72.16% | 1.40B | 368.80M | 0.33 |
| Q2 FY2017 | 30 Jun 2017 | 1.02B | +68.76% | 1.13B | 115.00M | 0.35 |
| Q1 FY2017 | 31 Mar 2017 | 847.90M | +40.80% | 918.20M | 70.30M | 0.31 |
| Q4 FY2016 | 31 Dec 2016 | 822.30M | +37.76% | 1.27B | 448.80M | 0.31 |
| Q3 FY2016 | 30 Sept 2016 | 600.60M | -0.71% | 1.20B | 599.70M | 0.22 |
| Q2 FY2016 | 30 Jun 2016 | 602.50M | +0.37% | 1.06B | 457.70M | 0.24 |
| Q1 FY2016 | 31 Mar 2016 | 602.20M | -0.08% | 951.80M | 349.60M | 0.26 |
| Q4 FY2015 | 31 Dec 2015 | 596.90M | -0.20% | 1.22B | 627.80M | 0.24 |
| Q3 FY2015 | 30 Sept 2015 | 604.90M | -0.84% | 1.25B | 645.60M | 0.25 |
| Q2 FY2015 | 30 Jun 2015 | 600.30M | +0.38% | 1.41B | 808.70M | 0.26 |
| Q1 FY2015 | 31 Mar 2015 | 602.70M | -16.91% | 1.37B | 768.10M | 0.27 |
| Q4 FY2014 | 31 Dec 2014 | 598.10M | +0.84% | 1.44B | 840.70M | 0.27 |
| Q3 FY2014 | 30 Sept 2014 | 610.00M | +14.64% | 1.52B | 905.10M | 0.30 |
| Q2 FY2014 | 30 Jun 2014 | 598.00M | +163.09% | 1.48B | 886.10M | 0.31 |
| Q1 FY2014 | 31 Mar 2014 | 725.40M | +276.44% | 831.60M | 106.20M | 0.54 |
| Q4 FY2013 | 31 Dec 2013 | 593.10M | +213.31% | 936.90M | 343.80M | 0.38 |
| Q3 FY2013 | 30 Sept 2013 | 532.10M | +203.36% | 757.60M | 225.50M | 0.37 |
| Q2 FY2013 | 30 Jun 2013 | 227.30M | +22.80% | 575.00M | 347.70M | 0.14 |
| Q1 FY2013 | 31 Mar 2013 | 192.70M | +7.41% | 557.90M | 365.20M | 0.12 |
| Q4 FY2012 | 31 Dec 2012 | 189.30M | +25.86% | 521.40M | 332.10M | 0.13 |
| Q3 FY2012 | 30 Sept 2012 | 175.40M | +0.23% | 622.50M | 447.10M | 0.11 |
| Q2 FY2012 | 30 Jun 2012 | 185.10M | +5.89% | 506.00M | 320.90M | 0.13 |
| Q1 FY2012 | 31 Mar 2012 | 179.40M | +20.00% | 409.50M | 230.10M | 0.13 |
| Q4 FY2011 | 31 Dec 2011 | 150.40M | +259.81% | 450.50M | 300.10M | 0.11 |
| Q3 FY2011 | 30 Sept 2011 | 175.00M | +73.96% | 451.10M | 276.10M | 0.13 |
| Q2 FY2011 | 30 Jun 2011 | 174.80M | -1.52% | 468.20M | 293.40M | 0.13 |
| Q1 FY2011 | 31 Mar 2011 | 149.50M | +15.62% | 433.80M | 284.30M | 0.11 |
| Q4 FY2010 | 31 Dec 2010 | 41.80M | -53.71% | 396.10M | 354.30M | 0.03 |
| Q3 FY2010 | 30 Sept 2010 | 100.60M | -1.66% | 361.00M | 260.40M | 0.08 |
| Q2 FY2010 | 30 Jun 2010 | 177.50M | +55.84% | 320.30M | 142.80M | 0.16 |
| Q1 FY2010 | 31 Mar 2010 | 129.30M | +5.12% | 321.20M | 191.90M | 0.11 |
| Q4 FY2009 | 31 Dec 2009 | 90.30M | -48.55% | 334.10M | 243.80M | 0.08 |
| Q3 FY2009 | 30 Sept 2009 | 102.30M | -49.56% | 289.50M | 187.20M | 0.09 |
| Q2 FY2009 | 30 Jun 2009 | 113.90M | -19.62% | 188.30M | 74.40M | 0.11 |
| Q1 FY2009 | 31 Mar 2009 | 123.00M | -42.23% | 150.40M | 27.40M | 0.13 |
| Q4 FY2008 | 31 Dec 2008 | 175.50M | -17.10% | 226.80M | 51.30M | 0.20 |
| Q3 FY2008 | 30 Sept 2008 | 202.80M | -3.98% | 214.50M | 11.70M | 0.23 |
| Q2 FY2008 | 30 Jun 2008 | 141.70M | -31.74% | 208.10M | 66.40M | 0.16 |
| Q1 FY2008 | 31 Mar 2008 | 212.90M | -5.17% | 189.60M | -23.30M | 0.27 |
| Q4 FY2007 | 31 Dec 2007 | 211.70M | -10.26% | 191.20M | -20.50M | 0.25 |
| Q3 FY2007 | 30 Sept 2007 | 211.20M | -16.52% | 175.70M | -35.50M | 0.26 |
| Q2 FY2007 | 30 Jun 2007 | 207.60M | -25.75% | 164.90M | -42.70M | 0.26 |
| Q1 FY2007 | 31 Mar 2007 | 224.50M | -22.32% | 180.20M | -44.30M | 0.29 |
| Q4 FY2006 | 31 Dec 2006 | 235.90M | -25.37% | 182.80M | -53.10M | 0.31 |
| Q3 FY2006 | 30 Sept 2006 | 253.00M | +0.60% | 151.30M | -101.70M | 0.35 |
| Q2 FY2006 | 30 Jun 2006 | 279.60M | +3.71% | 167.10M | -112.50M | 0.39 |
| Q1 FY2006 | 31 Mar 2006 | 289.00M | +4.79% | 189.00M | -100.00M | 0.40 |
| Q4 FY2005 | 31 Dec 2005 | 316.10M | +18.35% | 178.60M | -137.50M | 0.46 |
| Q3 FY2005 | 30 Sept 2005 | 251.50M | -6.58% | 88.00M | -163.50M | 0.38 |
| Q2 FY2005 | 30 Jun 2005 | 269.60M | -13.81% | 96.10M | -173.50M | 0.41 |
| Q1 FY2005 | 31 Mar 2005 | 275.80M | -17.55% | 72.60M | -203.20M | 0.43 |
| Q4 FY2004 | 31 Dec 2004 | 267.10M | +4.42% | 48.90M | -218.20M | 0.43 |
| Q3 FY2004 | 30 Sept 2004 | 269.20M | -8.15% | 31.00M | -238.20M | 0.45 |
| Q2 FY2004 | 30 Jun 2004 | 312.80M | +1.79% | 40.00M | -272.80M | 0.53 |
| Q1 FY2004 | 31 Mar 2004 | 334.50M | +20.80% | 37.90M | -296.60M | 0.59 |
| Q4 FY2003 | 31 Dec 2003 | 255.80M | +4.20% | 61.10M | -194.70M | 0.40 |
| Q3 FY2003 | 30 Sept 2003 | 293.10M | +4.72% | 38.30M | -254.80M | 0.51 |
| Q2 FY2003 | 30 Jun 2003 | 307.30M | +3.29% | 50.70M | -256.60M | 0.55 |
| Q1 FY2003 | 31 Mar 2003 | 276.90M | -5.27% | 29.80M | -247.10M | 0.51 |
| Q4 FY2002 | 31 Dec 2002 | 245.50M | -21.04% | 34.20M | -211.30M | 0.46 |
| Q3 FY2002 | 30 Sept 2002 | 279.90M | -17.51% | 39.00M | -240.90M | 0.61 |
| Q2 FY2002 | 30 Jun 2002 | 297.50M | -23.36% | 35.50M | -262.00M | 0.62 |
| Q1 FY2002 | 31 Mar 2002 | 292.30M | -29.46% | 28.00M | -264.30M | 0.60 |
| Q4 FY2001 | 31 Dec 2001 | 310.90M | -27.36% | 48.00M | -262.90M | 0.68 |
| Q3 FY2001 | 30 Sept 2001 | 339.30M | -31.98% | 23.50M | -315.80M | 0.82 |
| Q2 FY2001 | 30 Jun 2001 | 388.20M | -26.89% | 61.60M | -326.60M | 0.93 |
| Q1 FY2001 | 31 Mar 2001 | 414.40M | -21.66% | 17.90M | -396.50M | 0.89 |
| Q4 FY2000 | 31 Dec 2000 | 428.00M | — | 28.00M | -400.00M | 0.97 |
| Q3 FY2000 | 30 Sept 2000 | 498.80M | — | 13.20M | -485.60M | 1.18 |
| Q2 FY2000 | 30 Jun 2000 | 531.00M | — | 2.00M | -529.00M | 1.29 |
| Q1 FY2000 | 31 Mar 2000 | 529.00M | — | 6.00M | -523.00M | 0.77 |
| Q4 FY1999 | 31 Dec 1999 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
Total debt counts commercial paper, term debt and lease liabilities.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet
Common questions about Edwards Lifesciences's debt
Source: Financial Modeling Prep